Global Liquid Biopsy Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Biomarker, By Source, By Clinical Application, By Indication, By Geographic Coverage and By Company)
Published Date: Jul 2023 |
Format:
| No. of Pages: 210
The global liquid biopsy market size is anticipated to reach US$15.4 Bn in 2030.
The global liquid biopsy market is anticipated to witness a CAGR of 19.5% during the forecast period 2023-2030.
The circulating free DNA (cfDNA) type is anticipated to dominate the market with a contribution of ~28% by the end of forecast period.
Treatment selection holds the largest market share with the value expected to reach more than US$5.5 Bn in 2030, whereas the diagnosis and screening segment will exhibit faster growth.
North America currently leads the global liquid biopsy market in terms of value, reaching an estimated value of US$6.9 Bn by 2030-end.